These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment. Doycheva D; Shih G; Chen H; Applegate R; Zhang JH; Tang J Transl Stroke Res; 2013 Apr; 4(2):171-8. PubMed ID: 23565130 [TBL] [Abstract][Full Text] [Related]
12. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke. Dela Peña IC; Yang S; Shen G; Fang Liang H; Solak S; Borlongan CV Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857523 [TBL] [Abstract][Full Text] [Related]
13. Comparison of autologous bone marrow mononuclear cells transplantation and mobilization by granulocyte colony-stimulating factor in experimental spinal injury. Guo X; Bu X; Li Z; Yan Z; Jiang J; Zhou Z Int J Neurosci; 2012 Dec; 122(12):723-33. PubMed ID: 22862301 [TBL] [Abstract][Full Text] [Related]
14. Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy. Diederich K; Quennet V; Bauer H; Müller HD; Wersching H; Schäbitz WR; Minnerup J; Sommer C Stroke; 2012 Jan; 43(1):185-92. PubMed ID: 22020031 [TBL] [Abstract][Full Text] [Related]
15. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Luo J; Zhang HT; Jiang XD; Xue S; Ke YQ Acta Neurochir (Wien); 2009 Nov; 151(11):1483-92. PubMed ID: 19499175 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid enhances the effect of bone marrow-derived mononuclear cells in a rat ischemic stroke model. Suda S; Katsura KI; Saito M; Kamiya N; Katayama Y Brain Res; 2014 May; 1565():74-81. PubMed ID: 24746498 [TBL] [Abstract][Full Text] [Related]
17. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation. Aksu T; Ok Bozkaya İ; Akpınar Tekgündüz S; Olcar Kanbur M; Köksal Y; Özgüner M; Özbek NY Transfus Apher Sci; 2017 Dec; 56(6):829-831. PubMed ID: 29153311 [TBL] [Abstract][Full Text] [Related]
18. Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF). Chiba Y; Kuroda S; Osanai T; Shichinohe H; Houkin K; Iwasaki Y Neuropathology; 2012 Apr; 32(2):139-48. PubMed ID: 21981141 [TBL] [Abstract][Full Text] [Related]
19. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Sprigg N; Bath PM; Zhao L; Willmot MR; Gray LJ; Walker MF; Dennis MS; Russell N Stroke; 2006 Dec; 37(12):2979-83. PubMed ID: 17082474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]